Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $4.00 Consensus Price Target from Analysts

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has received a consensus recommendation of “Hold” from the four ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $4.00.

A number of research analysts recently issued reports on the stock. Wall Street Zen cut shares of Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research note on Saturday, April 4th. Weiss Ratings cut shares of Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a research note on Thursday.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Jones Financial Companies Lllp boosted its position in Bioceres Crop Solutions by 3,535.8% in the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock valued at $25,000 after buying an additional 5,339 shares in the last quarter. Bank of America Corp DE boosted its position in Bioceres Crop Solutions by 186.8% in the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after buying an additional 3,735 shares in the last quarter. Virtu Financial LLC acquired a new stake in Bioceres Crop Solutions in the third quarter valued at approximately $40,000. Invesco Ltd. acquired a new stake in Bioceres Crop Solutions in the fourth quarter valued at approximately $45,000. Finally, PDT Partners LLC boosted its position in Bioceres Crop Solutions by 58.9% in the second quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock valued at $126,000 after buying an additional 10,449 shares in the last quarter. 17.68% of the stock is owned by institutional investors.

Bioceres Crop Solutions Stock Performance

Shares of NASDAQ:BIOX opened at $0.42 on Wednesday. The company’s 50 day simple moving average is $0.49 and its 200 day simple moving average is $0.81. The stock has a market capitalization of $26.56 million, a price-to-earnings ratio of -0.11 and a beta of 0.39. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.88 and a quick ratio of 0.70. Bioceres Crop Solutions has a 1 year low of $0.35 and a 1 year high of $5.15.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings data on Monday, May 11th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.11). The firm had revenue of $39.40 million during the quarter, compared to the consensus estimate of $54.50 million. Bioceres Crop Solutions had a negative net margin of 92.85% and a negative return on equity of 33.97%. As a group, research analysts predict that Bioceres Crop Solutions will post -0.16 EPS for the current fiscal year.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.